Table 2.
Level of evidence | Diagnostics | Therapy |
---|---|---|
Ia | SR (with homogeneity*) of level 1 diagnostic studies; clinical decision rule with 1b studies from different clinical centres | SR (with homogeneity*) of RCTs |
Ib | Validating cohort study with good reference standards or clinical decision rule tested within 1 clinical centre | Individual RCT (with narrow confidence interval) |
Ic | Absolute SpPins and SnNouts | All or none principle |
IIa | SR (with homogeneity*) of level >2 diagnostic studies | SR (with homogeneity) of cohort studies |
IIb | Exploratory cohort study with good reference standards, clinical decision rule after derivation, or validated only on split-sample or databases | Individual cohort study (including low quality RCT) |
IIc | Outcomes research, ecological studies | |
IIIa | SR (with homogeneity*) of 3b and better studies | SR (with homogeneity) of case-control studies |
IIIb | Non-consecutive study, or without consistently applied reference standards | Individual case-control study |
IV | Case-control study, poor or non-independent reference standard | Case series (and poor-quality cohort and case-control studies) |
V | Expert opinion without explicit critical appraisal, or based on physiology, bench research or first principles | Expert opinion without explicit critical appraisal, or based on physiology, bench research or first principles |
RCT, randomized control trial; SR, systematic review.
By homogeneity, we mean a systematic review that is free of worrisome variations (heterogeneity) in the directions and degrees of results between individual studies. Not all systematic reviews with statistically significant heterogeneity need be worrisome, and not all worrisome heterogeneity need be statistically significant.